AllCell consortium launches Jordan solar EV project with Nissan
DSME and GL offer solution to LNG-fueled large container vessels

Amyris to buy Draths

ICIS Green Chemicals reports that, according to a filing with the SEC, renewable fuels and chemicals company Amyris is buying Michigan-based Draths Corporation for an undisclosed sum. The Lansing Journal reported on 18 October that the Draths had been purchased and will lay off all but two of its 40 employees. The buyer was not then named.

Draths, using proprietary microorganisms developed by its synthetic biology group, has developed fermentation methods that optimally convert sugars into chemical intermediates.

Draths’ first two commercial product targets were caprolactum, produced from its Lysine technology platform; and Purified Terephthalic Acid (PTA) produced from its muconic acid technology platform. Products awaiting funding for commercialization included adipic acid; hexamethylene diamine (HMDA); protocatechuic acid; catechol; caprolactone; hexanediol; resorcinol, etc.

Draths’ product plans. Click to enlarge.


The comments to this entry are closed.